NO921451L - Heterocykliske amider - Google Patents

Heterocykliske amider

Info

Publication number
NO921451L
NO921451L NO92921451A NO921451A NO921451L NO 921451 L NO921451 L NO 921451L NO 92921451 A NO92921451 A NO 92921451A NO 921451 A NO921451 A NO 921451A NO 921451 L NO921451 L NO 921451L
Authority
NO
Norway
Prior art keywords
aryl
hydrogen
formula
heteroaryl
group
Prior art date
Application number
NO92921451A
Other languages
English (en)
Norwegian (no)
Other versions
NO921451D0 (no
Inventor
Peter Robert Bernstein
Andrew Shaw
Royston Martin Thomas
Peter Warner
Donald John Wolanin
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919108357A external-priority patent/GB9108357D0/en
Priority claimed from GB919108358A external-priority patent/GB9108358D0/en
Priority claimed from GB929205392A external-priority patent/GB9205392D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO921451D0 publication Critical patent/NO921451D0/no
Publication of NO921451L publication Critical patent/NO921451L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO92921451A 1991-04-18 1992-04-10 Heterocykliske amider NO921451L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919108357A GB9108357D0 (en) 1991-04-18 1991-04-18 Heterocyclic amides
GB919108358A GB9108358D0 (en) 1991-04-18 1991-04-18 Heterocyclic compounds
GB929205392A GB9205392D0 (en) 1992-03-12 1992-03-12 Heterocyclic amides

Publications (2)

Publication Number Publication Date
NO921451D0 NO921451D0 (no) 1992-04-10
NO921451L true NO921451L (no) 1992-10-19

Family

ID=27265602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921451A NO921451L (no) 1991-04-18 1992-04-10 Heterocykliske amider

Country Status (15)

Country Link
EP (1) EP0509769B1 (fi)
JP (1) JPH0656785A (fi)
KR (1) KR920019750A (fi)
AU (1) AU660664B2 (fi)
CA (1) CA2065794A1 (fi)
CS (1) CS117692A3 (fi)
DE (1) DE69213537T2 (fi)
FI (1) FI921598A (fi)
GB (1) GB9207145D0 (fi)
HU (1) HUT66541A (fi)
IE (1) IE921159A1 (fi)
IL (1) IL101555A0 (fi)
NO (1) NO921451L (fi)
NZ (1) NZ242322A (fi)
TW (1) TW262475B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
WO1993021214A1 (en) * 1992-04-16 1993-10-28 Zeneca Limited Alpha-aminoboronic acid peptides and their use as elastase inhibitors
CA2133658A1 (en) * 1992-04-16 1993-10-28 Peter R. Bernstein Heterocyclic derivatives
GB9307555D0 (en) * 1992-04-16 1993-06-02 Zeneca Ltd Heterocyclic compounds
US5441960A (en) * 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9214053D0 (en) * 1992-07-02 1992-08-12 Ici Plc Heterocyclic amides
US5658930A (en) * 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US6608204B1 (en) * 1994-12-13 2003-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5656645A (en) * 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
EP0826671B1 (en) * 1995-04-27 2004-12-29 Mitsubishi Pharma Corporation Heterocyclic amide compounds and medicinal use of the same
EP0835109A4 (en) * 1995-06-27 1999-02-03 Merck & Co Inc PYRIDINONE-BASED THROMBIN INHIBITORS
US5668289A (en) * 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5872138A (en) * 1996-09-13 1999-02-16 Merck & Co., Inc. Thrombin inhibitors
US5869487A (en) * 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
WO1998018794A1 (fr) * 1996-10-25 1998-05-07 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales
US6017934A (en) * 1997-01-22 2000-01-25 Merck & Co., Inc. Thrombin inhibitors
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
US6011038A (en) * 1997-09-05 2000-01-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6087373A (en) * 1997-09-23 2000-07-11 Merck & Co., Inc. Thrombin inhibitors
US6133297A (en) * 1997-09-30 2000-10-17 Merck & Co., Inc. Thrombin inhibitors
US6528514B1 (en) 1998-03-11 2003-03-04 Welfide Corporation IgE antibody production inhibitors and autoimmune diseases inhibitors
US6147078A (en) * 1998-05-19 2000-11-14 Merck & Co., Inc. Pyrazinone thrombin inhibitors
EP1117660A4 (en) * 1998-09-28 2002-01-09 Merck & Co Inc THROMBIN INHIBITORS
CA2348530A1 (en) 1998-10-30 2000-05-11 Merck & Co., Inc. Thrombin inhibitors
US6610692B1 (en) 1998-10-30 2003-08-26 Merck & Co., Inc. Thrombin inhibitors
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
UA58636C2 (uk) 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
CA2374654A1 (en) 1999-06-04 2000-12-14 Merck & Co., Inc. Thrombin inhibitors
JP2003514905A (ja) 1999-11-23 2003-04-22 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
CA2403558A1 (en) 2000-03-23 2001-09-27 Merck & Co., Inc. Thrombin inhibitors
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
PE20050159A1 (es) * 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
SE0302487D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
RU2412936C2 (ru) 2004-11-24 2011-02-27 Вертекс Фармасьютикалз Инкорпорейтед Производные 3-[2-(3-ациламино-2-оксо-2н-пиридин-1-ил)-ацетиламино]-4-оксо-пентановой кислоты и их применение в качестве ингибиторов каспазы
AU2006255009B2 (en) * 2005-06-07 2011-10-27 Pharmacopeia L.L.C. Azinone and diazinone V3 inhibitors for depression and stress disorders
RU2007147959A (ru) * 2005-06-08 2009-07-20 Новартис АГ (CH) Органические соединения
CN110950807B (zh) * 2018-09-26 2023-03-03 中国科学院上海药物研究所 联芳基类化合物、其制备方法、药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives

Also Published As

Publication number Publication date
DE69213537T2 (de) 1997-02-20
JPH0656785A (ja) 1994-03-01
FI921598A0 (fi) 1992-04-10
EP0509769A2 (en) 1992-10-21
EP0509769A3 (en) 1993-09-01
IL101555A0 (en) 1992-12-30
AU1482792A (en) 1992-10-22
DE69213537D1 (de) 1996-10-17
HUT66541A (en) 1994-12-28
IE921159A1 (en) 1992-10-21
KR920019750A (ko) 1992-11-19
TW262475B (en) 1995-11-11
FI921598A (fi) 1992-10-19
CS117692A3 (en) 1992-11-18
NZ242322A (en) 1994-12-22
CA2065794A1 (en) 1992-10-19
NO921451D0 (no) 1992-04-10
EP0509769B1 (en) 1996-09-11
GB9207145D0 (en) 1992-05-13
AU660664B2 (en) 1995-07-06
HU9201225D0 (en) 1992-07-28

Similar Documents

Publication Publication Date Title
NO921451L (no) Heterocykliske amider
DK34793D0 (da) Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det
ES8605511A1 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES8101563A1 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
ES8402268A1 (es) Un procedimiento para la preparacion de un derivado del indol.
ES465529A1 (es) Procedimiento para la obtencion de nuevas feniletilaminas.
MY103905A (en) Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same.
GR76356B (fi)
GB1298112A (en) Phenyl acetyl guanidine derivatives
TW222268B (fi)
DK23089D0 (da) Thioformamidderivater og deres anvendelse
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
HUT43568A (en) Process for preparing novel 2-pyridiyl-acetic acid derivatives and pharmaceutics comprising the same
GB1142508A (en) Pyrrole derivatives
DK48188D0 (da) Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf
IL66384A0 (en) Sulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
HUT60261A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
GB1292094A (en) A phenylglycine derivative
GB1469410A (en) Benzodioxole derivatives
ES8506725A1 (es) Procedimiento para la preparacion de un derivado de cefalosporina
ES8604233A1 (es) Procedimiento de preparacion de sales sodicas de antibioticos beta-lactamicos
ES324379A1 (es) Un metodo para la preparacion de derivados basicos de ftalanos e isocromanos.